Oct. 9, 2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer ... stops escaped cancer cells from developing into tumors elsewhere in ...

In this randomized controlled trial, adjuvant therapy with durvalumab led to improved overall and progression-free survival ...

Lung cancer begins with lung cells that have changed, multiplied, and then grouped to form a tumor. This cancer can ... Most lung cancers are called non-small cell lung cancer (NSCLC).

A new study published in the Journal of Clinical Investigation found that COVID was linked to cancer regression, which could ...

Last November, Pyxis revealed it would continue to focus on PYX-201 as its lead asset, while pausing other early-stage ...

Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.

Immune cells produced during severe COVID-19 infection may shrink tumors. The unexpected mechanism offers a new therapeutic ...

The study examined genetic alterations in more than 3,200 patients with lung cancer, focusing on key genes linked to ...

The Lung Cancer Research Foundation (LCRF) and the International Association for the Study of Lung Cancer (IASLC) today ...

After feedback from the FDA, the companies have voluntarily withdrawn the previous biologics licensing application for ...